AUB
INO icon

Atlantic Union Bankshares’s Inovio Pharmaceuticals INO Stock Holding History

Atlantic Union Bankshares’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1 Hold
1
– – ﹤0.01% 1699
2026
Q1 		$2 Hold
1
– – ﹤0.01% 1747
2025
Q4 		$2 Hold
1
– – ﹤0.01% 1686
2025
Q3 		$2 Buy
+1
New +$2 ﹤0.01% 1650

Other funds holding INO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Atlantic Union Bankshares's INO Position: Q2 2026 in Review

Atlantic Union Bankshares held its Inovio Pharmaceuticals (INO) position steady in Q2 2026 at 1 share worth $1. The position accounts for ﹤0.01% of the portfolio, ranked #1699.

Atlantic Union Bankshares first reported a position in INO in Q3 2025 and has held it in 4 quarters since. The position peaked at $2 in Q1 2026. 102 funds tracked by Wall St. Rank hold INO as of Q2 2026.

  • Atlantic Union Bankshares held 1 share of Inovio Pharmaceuticals worth $1 as of Q2 2026.
  • Atlantic Union Bankshares left its Inovio Pharmaceuticals share count unchanged in Q2 2026.
  • Inovio Pharmaceuticals made up ﹤0.01% of Atlantic Union Bankshares's portfolio in Q2 2026, its #1699 holding.
  • Atlantic Union Bankshares first reported a position in Inovio Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • Atlantic Union Bankshares's Inovio Pharmaceuticals position peaked at $2 in Q1 2026.
  • 102 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2026.

Based on Atlantic Union Bankshares's 13F filing for Q2 2026, filed 11 Aug 2026.